These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 20529331

  • 1. Vaccination response to protein and carbohydrate antigens in patients with rheumatoid arthritis after rituximab treatment.
    Rehnberg M, Brisslert M, Amu S, Zendjanchi K, Håwi G, Bokarewa MI.
    Arthritis Res Ther; 2010; 12(3):R111. PubMed ID: 20529331
    [Abstract] [Full Text] [Related]

  • 2. The cellular immune response to influenza vaccination is preserved in rheumatoid arthritis patients treated with rituximab.
    Arad U, Tzadok S, Amir S, Mandelboim M, Mendelson E, Wigler I, Sarbagil-Maman H, Paran D, Caspi D, Elkayam O.
    Vaccine; 2011 Feb 11; 29(8):1643-8. PubMed ID: 21211590
    [Abstract] [Full Text] [Related]

  • 3. Rituximab impairs immunoglobulin (Ig)M and IgG (subclass) responses after influenza vaccination in rheumatoid arthritis patients.
    Westra J, van Assen S, Wilting KR, Land J, Horst G, de Haan A, Bijl M.
    Clin Exp Immunol; 2014 Oct 11; 178(1):40-7. PubMed ID: 24889761
    [Abstract] [Full Text] [Related]

  • 4. Effect of methotrexate, anti-tumor necrosis factor α, and rituximab on the immune response to influenza and pneumococcal vaccines in patients with rheumatoid arthritis: a systematic review and meta-analysis.
    Hua C, Barnetche T, Combe B, Morel J.
    Arthritis Care Res (Hoboken); 2014 Jul 11; 66(7):1016-26. PubMed ID: 24339395
    [Abstract] [Full Text] [Related]

  • 5. Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab.
    van Assen S, Holvast A, Benne CA, Posthumus MD, van Leeuwen MA, Voskuyl AE, Blom M, Risselada AP, de Haan A, Westra J, Kallenberg CG, Bijl M.
    Arthritis Rheum; 2010 Jan 11; 62(1):75-81. PubMed ID: 20039396
    [Abstract] [Full Text] [Related]

  • 6. Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis.
    Crnkic Kapetanovic M, Saxne T, Jönsson G, Truedsson L, Geborek P.
    Arthritis Res Ther; 2013 Oct 30; 15(5):R171. PubMed ID: 24286269
    [Abstract] [Full Text] [Related]

  • 7. B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agents.
    Finckh A, Ciurea A, Brulhart L, Kyburz D, Möller B, Dehler S, Revaz S, Dudler J, Gabay C, Physicians of the Swiss Clinical Quality Management Program for Rheumatoid Arthritis.
    Arthritis Rheum; 2007 May 30; 56(5):1417-23. PubMed ID: 17469098
    [Abstract] [Full Text] [Related]

  • 8. Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept.
    Alten R, Bingham CO, Cohen SB, Curtis JR, Kelly S, Wong D, Genovese MC.
    BMC Musculoskelet Disord; 2016 May 26; 17():231. PubMed ID: 27229685
    [Abstract] [Full Text] [Related]

  • 9. Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial.
    Bingham CO, Looney RJ, Deodhar A, Halsey N, Greenwald M, Codding C, Trzaskoma B, Martin F, Agarwal S, Kelman A.
    Arthritis Rheum; 2010 Jan 26; 62(1):64-74. PubMed ID: 20039397
    [Abstract] [Full Text] [Related]

  • 10. A Systematic Review and Metaanalysis of Antirheumatic Drugs and Vaccine Immunogenicity in Rheumatoid Arthritis.
    Subesinghe S, Bechman K, Rutherford AI, Goldblatt D, Galloway JB.
    J Rheumatol; 2018 Jun 26; 45(6):733-744. PubMed ID: 29545454
    [Abstract] [Full Text] [Related]

  • 11. Vaccine responses in patients with rheumatoid arthritis treated with certolizumab pegol: results from a single-blind randomized phase IV trial.
    Kivitz AJ, Schechtman J, Texter M, Fichtner A, de Longueville M, Chartash EK.
    J Rheumatol; 2014 Apr 26; 41(4):648-57. PubMed ID: 24584918
    [Abstract] [Full Text] [Related]

  • 12. Rituximab or a second anti-tumor necrosis factor therapy for rheumatoid arthritis patients who have failed their first anti-tumor necrosis factor therapy? Comparative analysis from the British Society for Rheumatology Biologics Register.
    Soliman MM, Hyrich KL, Lunt M, Watson KD, Symmons DP, Ashcroft DM, British Society for Rheumatology Biologics Register.
    Arthritis Care Res (Hoboken); 2012 Aug 26; 64(8):1108-15. PubMed ID: 22422731
    [Abstract] [Full Text] [Related]

  • 13. Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response.
    Oren S, Mandelboim M, Braun-Moscovici Y, Paran D, Ablin J, Litinsky I, Comaneshter D, Levartovsky D, Mendelson E, Azar R, Wigler I, Balbir-Gurman A, Caspi D, Elkayam O.
    Ann Rheum Dis; 2008 Jul 26; 67(7):937-41. PubMed ID: 17981914
    [Abstract] [Full Text] [Related]

  • 14. Immune response to influenza vaccine and pneumococcal polysaccharide vaccine under IL-6 signal inhibition therapy with tocilizumab.
    Tsuru T, Terao K, Murakami M, Matsutani T, Suzaki M, Amamoto T, Nakashima H, Akiyama A, Nishimoto N.
    Mod Rheumatol; 2014 May 26; 24(3):511-6. PubMed ID: 24252023
    [Abstract] [Full Text] [Related]

  • 15. Baseline serum immunoglobulin levels in patients with rheumatoid arthritis: relationships with clinical parameters and with B-cell dynamics following rituximab.
    de la Torre I, Leandro MJ, Edwards JC, Cambridge G.
    Clin Exp Rheumatol; 2012 May 26; 30(4):554-60. PubMed ID: 22510323
    [Abstract] [Full Text] [Related]

  • 16. Methotrexate reduces vaccine-specific immunoglobulin levels but not numbers of circulating antibody-producing B cells in rheumatoid arthritis after vaccination with a conjugate pneumococcal vaccine.
    Kapetanovic MC, Nagel J, Nordström I, Saxne T, Geborek P, Rudin A.
    Vaccine; 2017 Feb 07; 35(6):903-908. PubMed ID: 28081972
    [Abstract] [Full Text] [Related]

  • 17. Rituximab-treated patients have a poor response to influenza vaccination.
    Eisenberg RA, Jawad AF, Boyer J, Maurer K, McDonald K, Prak ET, Sullivan KE.
    J Clin Immunol; 2013 Feb 07; 33(2):388-96. PubMed ID: 23064976
    [Abstract] [Full Text] [Related]

  • 18. Epstein-Barr virus in bone marrow of rheumatoid arthritis patients predicts response to rituximab treatment.
    Magnusson M, Brisslert M, Zendjanchi K, Lindh M, Bokarewa MI.
    Rheumatology (Oxford); 2010 Oct 07; 49(10):1911-9. PubMed ID: 20547657
    [Abstract] [Full Text] [Related]

  • 19. Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent?
    Finckh A, Ciurea A, Brulhart L, Möller B, Walker UA, Courvoisier D, Kyburz D, Dudler J, Gabay C, Arthritis.
    Ann Rheum Dis; 2010 Feb 07; 69(2):387-93. PubMed ID: 19416802
    [Abstract] [Full Text] [Related]

  • 20. The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis.
    Elkayam O, Caspi D, Reitblatt T, Charboneau D, Rubins JB.
    Semin Arthritis Rheum; 2004 Feb 07; 33(4):283-8. PubMed ID: 14978666
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.